Patents Examined by M Walicka
  • Patent number: 7091014
    Abstract: The present invention relates to genetic engineering of production microorganisms used in biotechnology to improve their properties so that they produce useful products more efficiently. The microorganisms express at least one enzyme that causes the functional coupling of the oxidation and reduction of substrates by two pyridine nucleotide-linked dehydrogenase reactions with different specificities for the NAD/NADH and NADP/NADPH coenzyme couples and so facilitates the transfer of electrons between the two coenzyme couples through the said substrates. In particular the invention relates to increasing the yields of products such as ethanol or amino acids from carbon and nitrogen sources such as biomass comprising hexoes, pentoses or their polymers.
    Type: Grant
    Filed: March 11, 1999
    Date of Patent: August 15, 2006
    Assignee: Valtion Teknillinen Tutkimuskeskus
    Inventors: Aristos Aristidou, John Londesborough, Merja Penttilä, Peter Richard, Laura Ruohonen, Hans Söderlund, Anita Teleman, Mervi Toivari
  • Patent number: 6953684
    Abstract: The present invention provides a microorganism for the production of 1,3-propanediol from a variety of carbon sources in an organism capable of 1,3-propanediol production and comprising a) at least one gene encoding a dehydratase activity; b) at least one gene encoding a glycerol-3-phosphatase; and c) at least one gene encoding protein X. The protein X may be derived from a Klebsiella or Citrobacter gene cluster. The recombinant microorganism may further comprise d) at least one gene encoding a protein having at least 50% similarity to a protein selected from the group consisting of protein 1 (SEQ ID NO:60 or SEQ ID NO:61), of protein 2 (SEQ ID NO:62 or SEQ ID NO:63) and of protein 3 (SEQ ID NO:64 or SEQ ID NO:65) from Klebsiella or Citrobacter.
    Type: Grant
    Filed: November 13, 1997
    Date of Patent: October 11, 2005
    Assignee: Genencor International, Inc.
    Inventors: Nigel Dunn-Coleman, Maria Diaz-Torres, Matthew W. Chase, Donald Trimbur
  • Patent number: 6855532
    Abstract: This invention relates to newly identified polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides, to their use in therapy and in identifying compounds which may be stimulators and/or inhibitors which are useful in therapy, and to production of such polypeptides and polynucleotides.
    Type: Grant
    Filed: May 20, 2002
    Date of Patent: February 15, 2005
    Assignee: Solvay Pharmaceuticals B.V.
    Inventors: Willy Deleersnijder, Rico Wiegers, Michael Weske
  • Patent number: 6368594
    Abstract: The present disclosure describes DNA damage endonucleases which exhibit broad specificity with respect to the types of structural aberrations in double stranded DNA. These enzymes recognize double stranded DNA with distortions in structure, wherein the distortions result from photoproducts, alkylation, intercalation, abasic sites, mismatched base pairs, cisplatin adducts and inappropriately incorporated bases (for example, 8-oxoguanine, inosine, xanthine, among others). The UVDE (Uve1p) of Schizosaccharomyces pombe, certain truncated forms of that UVDE (lacking from about 100 to about 250 amino acids of N-terminal sequence) and certain endonucleases from Homo sapiens, Neurospora crassa, Bacillus subtilis, and from Deinococcus radiodurans. The present disclosure further provides methods for cleaving double stranded DNA having structural distortions as set forth herein using the exemplified endonucleases or their stable, functional truncated derivatives.
    Type: Grant
    Filed: June 8, 1999
    Date of Patent: April 9, 2002
    Assignee: Emory University
    Inventors: Paul W. Doetsch, Balveen Kaur, Angela M. Avery
  • Patent number: 6365387
    Abstract: The invention provides fabG polypeptides and polynucleotides encoding fabG polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing fabG polypeptides to screen for antibacterial compounds.
    Type: Grant
    Filed: May 17, 2000
    Date of Patent: April 2, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Jianzhong Huang, Damien McDevitt
  • Patent number: 6355468
    Abstract: The present provides a Rhodotorula phenylalanine lyase polypeptide, polynucleotides that encode the polypeptide, and methods of obtaining and using these products. In particular the polypeptide can be employed for the production of phenylalanine, phenylalanine analogs, and optically active unnatural amino acids having phenylalanine-like structures.
    Type: Grant
    Filed: July 24, 2000
    Date of Patent: March 12, 2002
    Assignee: PCBU Services, Inc.,
    Inventors: Roberta K. Yoshida, Anna B. Kootstra
  • Patent number: 6331421
    Abstract: Methods and compositions are provided for the production of human superoxide dismutase and a novel protocol for enhancing efficiency of expression. The gene encoding for human superoxide dismutase is isolated and inserted into a vector in conjunction with a synthetic linker which provides for enhanced efficiency in translation. E. coli strain D1210 (pSODX8) was deposited at the A.T.C.C. on Sep. 27, 1983 and given Accession No. 39453. Yeast strain 2150-2-3 (pC1/1GAPSOD) and E. coli strains D1210 (pSOD11) and D1210 (pS20R) were deposited at the A.T.C.C. on May 9, 1984, and given Accession Nos. 20708, 39679 and 39,680, respectively.
    Type: Grant
    Filed: January 19, 1995
    Date of Patent: December 18, 2001
    Assignee: Chiron Corporation
    Inventors: Robert A. Hallewell, Guy T. Mullenbach
  • Patent number: 6294363
    Abstract: Disclosed are methods for rapidly and efficiently purifying proteasomes using fusion proteins having homology to ubiquitin using amino acid sequences adhered to a solid support.
    Type: Grant
    Filed: June 19, 1998
    Date of Patent: September 25, 2001
    Assignee: University of Medicine & Dentistry of New Jersey
    Inventor: Kiran Madura